The Chemours Company Gross Profit 2013–2025
The Chemours Company reported $902.00M of gross profit for fiscal 2025. That was 21.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -15.5%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $902.00M | 15.5% | -21.0% |
| FY 2024 | $1.14B | 19.8% | -12.3% |
| FY 2023 | $1.30B | 21.6% | -19.4% |
| FY 2022 | $1.62B | 23.8% | +17.0% |
| FY 2021 | $1.38B | 21.8% | +29.4% |
| FY 2020 | $1.07B | 21.5% | +0.4% |
| FY 2019 | $1.06B | 19.2% | -46.1% |
| FY 2018 | $1.97B | 29.7% | +13.0% |
| FY 2017 | $1.75B | 28.2% | +58.2% |
| FY 2016 | $1.10B | 20.4% | +15.5% |
| FY 2015 | $955.00M | 16.7% | -29.8% |
| FY 2014 | $1.36B | 21.1% | -7.1% |
| FY 2013 | $1.46B | 21.3% | — |
Source: The Chemours Company SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CC 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
The Chemours Company reported $902.00M of gross profit for fiscal 2025. That was 21.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -15.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for The Chemours Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThe Chemours Company — frequently asked questions
What is The Chemours Company's gross profit?
The Chemours Company (CC) reported gross profit of $902.00M for fiscal year 2025, per its SEC filings.
How has The Chemours Company's gross profit changed over time?
Between fiscal 2013 and 2025, CC's gross profit declined at roughly 4.0% per year (compound annual rate), from $1.46B to $902.00M.
Where does this data come from?
Figures are computed from The Chemours Company's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.